PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Mahler, Donald A.
TI  - Once-Daily QVA149 Improves Breathlessness in COPD Patients
DP  - 2013 Aug 01
TA  - MD Conference Express
PG  - 19--20
VI  - 13
IP  - 4
4099  - http://mdc.sagepub.com/content/13/4/19.short
4100  - http://mdc.sagepub.com/content/13/4/19.full
AB  - A once-daily inhaled dual bronchodilator consisting of a long-acting β2-agonist and a long-acting muscarinic antagonist significantly improved self-reported shortness of breath and lung function compared with placebo and tiotropium in patients with moderate to severe chronic obstructive pulmonary disease. This article discusses results of the Effect of QVA149 on Dyspnea in Patients With Chronic Obstructive Pulmonary Disease study [BLAZE; NCT01490125], a multicenter, randomized, blinded, double-dummy, placebo-controlled, 3-period, crossover trial.